A Phase 3, Multi-center, Prospective, Randomized, Placebo-Controlled, Delayed Treatment, Double-Blind Study to Evaluate the Effectiveness and Safety of a Single Oral Dose of SolosecTM Granules Containing 2 grams of Secnidazole for the Treatment of Trichomoniasis Save

Date Added
July 23rd, 2019
PRO Number
Pro00088644
Researcher
Gweneth Lazenby

List of Studies


Profiles_link
Keywords
Obstetrics and Gynecology
Summary

The purpose of this research study is to test the safety and effectiveness of an investigational drug (Solosec) for the treatment of trichomoniasis. Solosec was approved in the United States by the Food and Drug Administration (FDA) in 2017 for the treatment of bacterial vaginosis (BV) in adult women ages 18 years and older. The sponsor would like to gather additional information for the treatment of Solosec in adult women and girls ages 12 years and older diagnosed with trichomoniasis.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-9302
paynej@musc.edu

Specimen Procurement for NeuMoDx™ Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Assay Evaluation Save

Date Added
March 6th, 2019
PRO Number
Pro00084622
Researcher
Gweneth Lazenby

List of Studies


Profiles_link
Keywords
Obstetrics and Gynecology
Summary

The purpose of this research is to provide the sponsor vaginal and urine samples that the clinician has collected and the subject has self collected in order to study a new test being developed for the detection of Chlamydia trachomatis and
Neisseria gonorrhoeae.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-9302
paynej@musc.edu

Change_preferences

-- OR --

Create_login